STAT Plus: Pharmalittle: Gates Foundation and others plan $125 million coronavirus effort; India considers lifting export restrictions
Rushing to begin clinical trials on a potential coronavirus treatment, Gilead Sciences may have violated federal law, rather than wait for federal approval. […]
STAT Plus: Pharmalittle: Drug pricing legislation is on the back burner; FDA issues emergency use for old malaria drugs
The FDA issued an emergency use authorization for two old malaria drugs — hydroxychloroquine and chloroquine — touted by President Trump for combating Covid-19 despite a lack of evidence. […]
STAT Plus: Pharmalittle: States try to prevent hoarding of drug used for Covid-19; is BARDA ready for the coronavirus?
BARDA was created to invest in drug development projects that private industry would not touch, but some experts wonder if the agency is ready for Covid-19. […]